Cargando…

Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study

Most data on differentiated thyroid cancer (DTC) came from the Western world. We describe its salient characteristics and outcome from a Middle Eastern country. Patients and Methods. We studied all cases of TC seen during a 2-year period (2004-2005) seen at our institution. Results. A total of 600 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Ali S., Alomar, Haneen, Alzahrani, Nada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350345/
https://www.ncbi.nlm.nih.gov/pubmed/28348588
http://dx.doi.org/10.1155/2017/8423147
_version_ 1782514643329089536
author Alzahrani, Ali S.
Alomar, Haneen
Alzahrani, Nada
author_facet Alzahrani, Ali S.
Alomar, Haneen
Alzahrani, Nada
author_sort Alzahrani, Ali S.
collection PubMed
description Most data on differentiated thyroid cancer (DTC) came from the Western world. We describe its salient characteristics and outcome from a Middle Eastern country. Patients and Methods. We studied all cases of TC seen during a 2-year period (2004-2005) seen at our institution. Results. A total of 600 consecutive cases of DTC with a median age at diagnosis of 39 years (5–85) and the female : male ratio of 459 : 141 (76.5% : 23.5%). The cases included classical papillary thyroid cancer (PTC) in 77%, follicular variant PTC in 13.3%, follicular thyroid cancer in 3.2%, and other rare subtypes 6.5%. Total or near-total thyroidectomy was performed in 93%, central and/or lateral neck dissection in 64.5% of cases, and radioactive iodine ablation in 82% of cases. Additional therapies were administered to 154 patients (25.7%). At a median follow-up period of 7.63 years (0.22–13.1), 318 patients (53.3%) were in excellent response, 147 (24.5%) having an indeterminate response, 55 (9.2%) biochemically incomplete, 33 (5.5%) structurally incomplete, and 27 (4.5%) unclassifiable. Twenty cases died secondary to DTC (disease-specific mortality 3.3%). Conclusions. In Saudi Arabia, DTC is common and occurs at young age and predominantly in females. Although remission is common, persistent disease is also common but disease-specific mortality is low.
format Online
Article
Text
id pubmed-5350345
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-53503452017-03-27 Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study Alzahrani, Ali S. Alomar, Haneen Alzahrani, Nada Int J Endocrinol Clinical Study Most data on differentiated thyroid cancer (DTC) came from the Western world. We describe its salient characteristics and outcome from a Middle Eastern country. Patients and Methods. We studied all cases of TC seen during a 2-year period (2004-2005) seen at our institution. Results. A total of 600 consecutive cases of DTC with a median age at diagnosis of 39 years (5–85) and the female : male ratio of 459 : 141 (76.5% : 23.5%). The cases included classical papillary thyroid cancer (PTC) in 77%, follicular variant PTC in 13.3%, follicular thyroid cancer in 3.2%, and other rare subtypes 6.5%. Total or near-total thyroidectomy was performed in 93%, central and/or lateral neck dissection in 64.5% of cases, and radioactive iodine ablation in 82% of cases. Additional therapies were administered to 154 patients (25.7%). At a median follow-up period of 7.63 years (0.22–13.1), 318 patients (53.3%) were in excellent response, 147 (24.5%) having an indeterminate response, 55 (9.2%) biochemically incomplete, 33 (5.5%) structurally incomplete, and 27 (4.5%) unclassifiable. Twenty cases died secondary to DTC (disease-specific mortality 3.3%). Conclusions. In Saudi Arabia, DTC is common and occurs at young age and predominantly in females. Although remission is common, persistent disease is also common but disease-specific mortality is low. Hindawi Publishing Corporation 2017 2017-02-27 /pmc/articles/PMC5350345/ /pubmed/28348588 http://dx.doi.org/10.1155/2017/8423147 Text en Copyright © 2017 Ali S. Alzahrani et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Alzahrani, Ali S.
Alomar, Haneen
Alzahrani, Nada
Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study
title Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study
title_full Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study
title_fullStr Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study
title_full_unstemmed Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study
title_short Thyroid Cancer in Saudi Arabia: A Histopathological and Outcome Study
title_sort thyroid cancer in saudi arabia: a histopathological and outcome study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350345/
https://www.ncbi.nlm.nih.gov/pubmed/28348588
http://dx.doi.org/10.1155/2017/8423147
work_keys_str_mv AT alzahranialis thyroidcancerinsaudiarabiaahistopathologicalandoutcomestudy
AT alomarhaneen thyroidcancerinsaudiarabiaahistopathologicalandoutcomestudy
AT alzahraninada thyroidcancerinsaudiarabiaahistopathologicalandoutcomestudy